[Ovid] PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer

mohamedfathii17 Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-20 04:26
Reward10points

journalㄩAnti-Cancer Drugs

AuthorsㄩPeter G. Rose; Meng Yao; Laura M. Chambers; Haider Mahdi; Robert DeBernardo; Chad M. Michener; Miriam AlHilli; Stephanie Ricci; Roberto Vargas

Published dateㄩ2021-11-

DOIㄩ10.1097/cad.0000000000001219

PDF linkㄩhttps://journals.lww.com/10.1097/CAD.0000000000001219

Article linkㄩhttps://doi.org/10.1097/cad.0000000000001219

Article SourceㄩOvid Technologies (Wolters Kluwer Health)﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list